Abstract
Controversies on acetylcholine-induced increases or decreases in coronary blood flow arise from obvious species differences, the role of endothelium in mediating vascular smooth muscle responses, and the marked negative chronotropic and inotropic effects of acetylcholine. In man, there appears to be a predominant dilation of intact epicardial coronary arteries and a constriction of artherosclerotic segments. However, at present there is no evidence for a vagal initiation of myocardial ischemia.
Coronary vascular β-adrenergic receptors mediate dilation, but appear to be functionally insignificant during sympathetic activation. The β-adrenergic mechanism contributing to myocardial ischemia are indirect, mediated by a tachycardia-related redistribution of blood flow away from the ischemic myocardium. α-Adrenergic receptors mediating epicardial coronary artery constriction in experimental studies appear not to be responsible for the initiation of ischemia in patients with angina at rest. However, α-adrenergic constriction of coronary resistance vessels resulting in the precipitation of poststenotic myocardial ischemia was demonstrated in experimental studies and recently confirmed in patients with effort angina. Non-adrenergic, non-cholinergic neurotransmitters exist; however, their role in regulating coronary blood flow remains entirely unclear.
Similar content being viewed by others
References
Aizawa Y, Murata M, Hayashi M, Funazaki T, Ito S, Shibata A (1985) Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery. Jpn J Physiol 49: 584–588
Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988) Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. Am J Physiol 255: H601–H607
Anderson FL, Kralios AC, Hershberger R, Bristow MR (1988) Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J Cardiovasc Pharmacol 12: 365–371
Arthur JM, Bonham AC, Gutterman DD, Gebhart GF, Marcus ML, Brody MJ (1991) Coronary vasoconstriction during stimulation in hypothalamic defense region. Am J Physiol 260: R335-R345
Bache RJ, Cobb FR (1977) Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res 41: 648–653
Bassenge E, Walter P, Doutheil U (1967) Wirkungsumkehr der adrenergischen Coronargefässreaktion in Abhängigikeit vom Coronargefäßtonus. Pfluegers Arch 297: 146–155
Baumgart D, Ehring T, Kowallik P, Guth BD, Krajcar M, Heusch G (1993) The impact of α-adrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res 73: 869–886
Berkenboom G, Unger P (1991) Alpha-adrenergic coronary constriction in effort angina. In: Heusch G, Ross J (eds) Adrenergic mechanisms in myocardial ischemia; Steinkopff, Darmstadt, pp 359–369
Berkenboom GM, Abramowicz M, Vandermoten P, Degre SG (1986) Rote of alpha-adrenergic coronary tone in exercise-induced angina pectoris. Am J Cardiol 57: 195–198
Berne RM (1958) Effect of epinephrine and norepinephrine on coronary circulation. Circ Res 6: 644–655
Berne RM, DeGeest H, Levy MN (1965) Influence of the cardiac nerves on coronary resistance. Am J Physiol 208: 763–769
Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ (1987) Neurogenic regulation of coronary blood flow: evidence for a central nervous system pathway. Circ Res 61 (suppl II): II-42–II-46
Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ (1987) Electrical stimulation in perifornical lateral hypothalamus decreases coronary blood flow in cats. Am J Physiol 252: H474–H484
Borchard F (1978) The adrenergic nerves of the normal and the hypertrophied heart. Thieme Verlag Stuttgart 33: 1–68
Brown BG, Bolson EL, Dodge HT (1984) Dynamic mechanisms in human coronary stenosis. Circulation 70: 917–922
Brown BG, Lee AB, Bolson EL, Dodge HT (1984) Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 70: 18–24
Buck JD, Hardman HF, Warltier DC, Gross GJ (1981) Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis induced by beta blockade in the canine heart. Circulation 64: 708–715
Buffington CW, Feigl EO (1981) Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res 48: 416–423
Busch P, Deussen A, Heusch G (1988) Sympathetic effects on segmental coronary resistances and their role in coronary collateral perfusion. J Appl Cardiol 3: 145–160
Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, L'Abbate A (1994) Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther 8: 221–226
Chen DG, Dai X-Z, Zimmerman BG, Bache RJ (1988) Postsynaptic α1-and α2-adrenergic mechanisms in coronary vasoconstriction. J Cardiovasc Pharmacol 11: 61–67
Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A (1984) α-adrenergic receptors and coronary spasm: an elusive link. Circulation 69: 8–14
Chierchia S, Pratt T, DeCoster P, Maseri A (1985) Alpha-adrenergic control of collateral flow: another determinant of coronary flow reserve. Circulation 72 (suppl III): 190 (abstr.)
Chilian WM (1991) Functional distribution of α1- and α1-adrenergic receptors in the coronary microcirculation. Circulation 84: 2108–2122
Chilian WM, Ackell PH (1988) Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis. Circ Res 62: 216–225
Chilian WM, Boatwright RB, Shoji T, Griggs DM (1981) Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res 49: 866–876
Chilian WM, Harrison DG, Haws CW, Snyder WD, Marcus ML (1986) Adrenergic coronary tone during submaximal exercise in the dog is produced by circulating catecholamines. Evidence for adrenergic denervation supersensitivity in the myocardium but not in coronary vessels. Circ Res 58: 68–82
Chilian WM, Layne SM, Eastham CL, Marcus ML (1989) Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circ Res 64: 376–388
Clarke JG, Kerwin R, Larkin S, Lee Y, Yacoub M, Davies GJ, Hackett D, Dawbarn D, Bloom SR, Maseri A (1987) Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1,2: 1057–1059
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305: 627–629
Cohen RA (1988) Platelet 5-hydroxytryptamine and vascular adrenergic nerves. News Physiol Sci 3: 185–189
Cohen RA, Zitnay KM, Weisbrod RM (1987) Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo. Circ Res 61: 829–833
Collins P, Sheridan D (1985) Improvement in angina pectoris with alpha adrenoceptor blockade. Br Heart J 53: 488–492
Constantine JW, Lebel W (1980) Complete blockade by phenoxybenzamine of alpha 1-but not of alpha 2-vascular receptors in dogs and the effect of propranolol. Naunyn Schmiedebergs Arch Pharmacol 314: 149–156
Cox DA, Hintze TH, Vatner SF (1983) Effects of acetylcholine on large and small coronary arteries in conscious dogs. J Pharmacol Exp Ther 225: 764–769
Decker N, Schwartz PJ (1985) Postjunctional alpha1- and alpha2-adrenoceptors in the coronaries of the perfused guinea-pig heart. J Pharmacol Exp Ther 232: 251–257
Denn MJ, Stone HL (1976) Autonomic innervation of dog coronary arteries. J Appl Physiol 41: 30–35
Deussen A, Heusch G, Thämer V (1985) Alpha 2-adrenoceptor-mediated cornary vasoconstriction persists after exhaustion of coronary dilator reserve. Eur J Pharmacol 115: 147–153
Downey HF, Grice DP, Jones CE (1991) Systemic hypoxia activates a coronary vasconstrictor reflex response that is blocked by prazosin. J Cardiovasc Pharmacol 18: 657–664
Drexler H, Zeiher AM, Wollschläger H, Meinertz T, Just H, Bonzel T (1989) Flow-dependent coronary artery dilatation in humans. Circulation 80: 466–474
Ehring T, Krajcar M, Baumgart D, Kompa S, Hümmelgen M, Heusch G (1995) Cholinergic and alpha-adrenergic coronary vasomotion with increasing ischemia-reperfusion injury. Am J Physiol 268: H886–H894
Ellis AK, Kocke FJ (1979) Effects of preload on the transmural distribution of perfusion and pressure-flow relationships in the canine coronary vascular bed. Circ Res 46: 68–77
Ertl G, Bauer B, Becker H-H, Rose G (1993) Effects of neurotensin and neuropeptide Y on coronary circulation and myocardial function in dogs. Am J Physiol 264: H1062–H1068
Ezra D, Laurindo FRM, Eimerl J, Goldstein RE, Peck CC, Feuerstein G (1986) Tachykinin modulation of coronary blood flow. Eur J Pharmacol 122: 135–138
Ezra D, Laurindo FRM, Goldstein DS, Goldstein RE, Feuerstein G (1987) Calcitonin gene-related peptide: a potent modulator of coronary flow. Eur J Pharmacol 137: 101–105
Faber JE (1988) In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ Res 62: 37–50
Fam WM, McGregor M (1968) Effect of nitroglycerin and dipyridamole on regional coronary resistance Circ Res 22: 649–659
Feigl EO (1968) Carotid sinus reflex control of coronary blood flow. Circ Res 23: 223–237
Feigl EO (1969) Parasympathetic control of coronary blood flow in dogs. Circ Res 25: 509–519
Feigl EO (1975) Control of myocardial oxygen tension by sympathetic coronary vasoconstriction in the dog. Circ Res 37: 88–95
Feigl EO (1983) Coronary physiology. Physiol Rev 63: 1–205
Feigl EO (1987) The paradox of adrenergic coronary vasoconstriction. Circulation 76: 737–745
Feldman RD, Christy JP, Paul ST, Harrison DG (1989) β-adrenergic receptors on canine coronary collateral vessels: characterization and function. Am J Physiol 257: H1634–H1639
Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P (1988) Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest 81: 21–31
Franco-Cereceda A, Lundberg JM, Dahlöf C (1985) Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiol Scand 124: 361–369
Franco-Cereceda A, Öwall A, Settergren G, Sollevi A, Lundberg JM (1990) Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery. Cardiovasc Res 24: 242–246
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376
Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP (1986) Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 73: 865–876
Gerova M, Barta E, Gero J (1979) Sympathetic control of major coronary artery diameter in the dog. Circ Res 44: 459–467
Gerova M, Dolezel S, Gero J, Barta E (1979) Role of the vagus in control of the major conduit coronary artery in the dog. Physiol Bohemoslov 28: 299–307
Gewirtz H, Most AS, Williams DO (1982) The effect of generalized alphareceptor stimulation on regional myocardial blood flow distal to a seveere coronary artery stenosis. Circulation 65: 1329–1336
Giudicelli JF, Berdeaux A, Tato F, Garnier M (1980) Left stellate stimulation: regional myocardial flows and ischemic injury in dogs. Am J Physiol 239: H359–H364
Gould L, Reddy GV, Gombrecht RF (1973) Oral phentolamine in angina pectoris. Jpn Heart J 14: 393–397
Gregorini L, Fajadet J, Robert G, Cassagneau B, Bernis M, Marco J (1994) Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulatior 90: 895–907
Gu J, Polak JM, Adrian TE, Allen JM, Tatemoto K, Bloom SR (1983) Neuropeptide Tyrosine (NPY) — a major cardiac neuropeptide. Lancet 1: 1008–1010
Gulbenkian S, Opgaard OS, Ekman R, Andrade NC, Wharton J, Polak JM, Queiroz e Melo J, Edvinsson L (1993) Peptidergic innervation of human epicardial coronary arteries. Circ Res 73: 579–588
Gunther S, Green L, Muller JE, Mudge GH, Grossman W (1981) Prevention by nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation 63: 849–855
Guth BD, Heusch G, Seitelberger R, Ross Jr. J (1987) Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 60: 738–746
Guth BD, Heusch G, Seitelberger R, Ross Jr. J (1987) Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 75: 661–669
Guth BD, Miura T, Thaulow E, Heusch G, Ross Jr. J (1993) Alphaladrenergic blockade reduces exerciseinduced regional myocardial ischemia in dogs. Basic Res Cardiol 88: 282–296
Guth BD, Thaulow E, Heusch G, Seitelberger R, Ross Jr J (1990) Myocardial effects of selective alphaadrenoceptor blockade during exercise in dogs. Circ Res 66: 1703–1712
Gwirtz PA, Overn SP, Mass HJ, Jones CE (1986) Alpha 1-adrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol 250: H1117–H1126
Gwirtz PA, Stone HL (1982) Coronary blood flow changes following activation of adrenergic receptors in the conscious dog. Am J Physiol 243: H13–H19
Haass M, Cheng B, Richardt G, Lang RE, Schöning A (1989) Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of noradrenaline and neuropeptide Y in guinea pig heart. Naunyn Schmiedebergs Arch Pharmacol 339: 71–78
Hackett JG, Abboud FM, Mark AL, Schmid PG, Heistad DD (1972) Coronary vascular responses to stimulation of chemoreceptors and baroreceptors. Circ Res 31: 8–17
Hamilton FN, Feigl EO (1976) Coronary vascular sympathetic beta-receptor innervation. Am J Physiol 230: 1569–1576
Harrison DG, Chilian WM, Marcus ML (1986) Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res 59: 133–142
Hautamaa PV, Dai X-Z, Homans DC, Bache RJ (1989) Vasomotor activity of moderately well-developed canine coronary collateral circulation. Am J Physiol 256: H890–H897
Hautamaa PV, Dai XZ, Homans DC, Robb JF, Bache RJ (1987) Vasomotor properties of immature canine coronary collateral circulation. Am J Physiol 252: H1105–H1111
Haws CW, Green LS, Burgess MJ, Abildskov JA (1987) Effects of cardiac sympathetic nerve stimulation on regional coronary blood flow. Am J Physiol 252: H269–H274
Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL (1984) Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 54: 711–718
Heusch G (1990) α-adrenergic mechanisms in myocardial ischemia. Circulation 81: 1–13
Heusch G, Deussen A (1983) The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog. Circ Res 53: 8–15
Heusch G, Deussen A (1984) Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses. J Cardiovasc Pharmacol 6: 378–383
Heusch G, Deussen A, Schipke J, Thämer V (1984) α1-and α2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 6: 961–968
Heusch G, Guth BD, Seitelberger R, Ross Jr J (1987) Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary casodilator reserve by nifedipine. Circulation 75: 482–490
Heusch G, Seitelberger R, Guth BD, Ross Jr J (1986) Adrenergic mechanisms in myocardial ischemia. J Appl Cardiol 1: 125–142
Heusch G, Yoshimoto N, Heegemann H, Thämer V (1983) Interaction of methoxamine with compensatory vasodilation distal to coronary stenoses. Drug Res 33: 1647–1650
Heyndrickx GR, Muylaert P, Pannier JL (1982) α-adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol 242: H805–H809
Heyndrickx GR, Vilaine JP, Moerman EJ, Leusen I (1984) Role of prejunctional alpha 2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs. Circ Res 54: 683–693
Hirsch EF, Borghard-Erdle AM (1961) The innervation of the human heart. Arch Pathol 71: 384–407
Hodgson JM, Cohen MD, Szentpetery S, Thames MD (1989) Effects of regional α-and β-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 79: 797–809
Hodgson JM, Marshall JJ (1989) Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 79: 1043–1051
Hoffman JIE (1987) Transmural myocardial perfusion. Prog Cardiovasc Dis 29: 429–464
Holmgren S, Abrahamsson T, Almgren O (1985) Adrenergic innervation of coronary arteries and ventricular myocardium in the pig: fluorescence microscopic appearance in the normal state and after ischemia. Basic Res Cardiol 80: 18–26
Holtz J, Giesler M, Bassenge E (1983) Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation. Z Kardiol 72 (suppl 3): 98–106
Holtz J, Mayer E, Bassenge E (1977) Demonstration of alpha-adrenergic coronary control in different layers of canine myocardium by regional myocardial sympathectomy. Pfluegers Arch 372: 187–194
Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptors. Eur J Pharmacol 82: 199–202
Hopwood AM, Burnstock G (1987) ATP mediates coronary vasconstriction via P2x-purinoceptors and coronary vasodilatation via P2y-purinoceptors in the isolated perfused rat heart. Eur J Pharmacol 136: 49–54
Horio Y, Yasue H, Rokutanda M, Nakamura N, Ogawa H, Takaoka K, Matsuyama K, Kimura T (1986) Effects of intracoronary injection of acetylcholine on coronary arterial diameter. Am J Cardiol 57: 984–989
Hossack KF, Brown BG, Stewart DK, Dodge HT (1984) Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans. Circulation 70: 465–471
Huang AH, Feigl EO (1988) Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res 62: 286–298
Indolfi C, Piscione F, Villari B, Russolillo E, Rendina V, Golino P, Condorelli M, Chiariello M (1992) Role of α2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 86: 1116–1124
Ishikawa Y, Umemura S, Uchino K, Shindou T, Yasuda G, Minamisawa K, Hayashi S, Hirawa N, Ishii M (1991) Identification of an alpha2-adrenoceptor in human coronary arteries by radioligand binding assay. Life Sci 48: 2513–2518
Ito BR, Feigl EO (1985) Carotid baroreceptor reflex coronary vasodilation in the dog. Circ Res 56: 486–495
Ito BR, Feigl EO (1985) Carotid chemoreceptor reflex parasympathetic coronary vasodilation in the dog. Am J Physiol 249: H1167–H1175
Johannsen UJ, Mark AL, Marcus ML (1982) Responsiveness to cardiac sympathetic nerve stimulation during maximal coronary dilation produced by adenosine. Circ Res 50: 510–517
Jones CE, Liang IYS, Maulsby MR (1986) Cardiac and coronary effects of prazosin and phenoxybenzamine during coronary hypotension. J Pharmacol Exp Ther 236: 204–211
Jones CJH, DeFily DV, Patterson JL, Chilian WM (1993) Endothelium-dependent relaxation competes with a1-and a2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 87: 1264–1274
Jones LF, Brody MJ (1992) Characterization of coronary vasoconstriction produced by rostral ventrolateral medulla stimulation in rats. Am J Physiol 262: H437–H442
Kalsner S (1985) Cholinergic mechanisms in human coronary artery preparations: implications of species differences. J Physiol 358: 509–526
Kelley KO, Feigl EO (1978) Segmental alpha-receptor-mediated vasoconstriction in the canine coronary circulation. Circ Res 43: 908–917
Klocke FJ, Kaiser GA, Ross Jr J, Braunwald E (1965) An intrinsic adrenergic vasodilator mechanism in the coronary vascular bed of the dog. Circ Res 16: 376–382
Komaru T, Ashikawa K, Kanatsuka H, Sekiguchi N, Suzuki T, Takishima T (1990) Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart. Circ Res 67: 1142–1151
Kopia GA, Kopaciewicz LJ, Ruffolo Jr RR (1986) Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries. J Pharmacol Exp Ther 239: 641–647
Kulakowski EC, Lampson WG, Schffer SW, Lovenberg W (1983) Action of substance P on the working rat heart. Biochem Pharmacol 32: 1097–1100
Laxson DD, Dai X-Z, Homans DC, Bache RJ (1989) The role of α1- and α2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res 65: 1688–1697
Levene DL, Freeman MR (1976) α-adrenoceptor-mediated coronary artery spasm. J Am Med Assoc 236: 1018–1022
Liang IYS, Jones CE (1985) Alpha 1-adrenergic blockade increases coronary blood flow during coronary hypoperfusion. Am J Physiol 249: H1070–H1077
Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046–1051
Main JS, Forster C, Armstrong PW (1991) Inhibitory role of the coronary arterial endothelium to α-adrenergic stimulation in experimental heart failure. Circ Res 68: 940–946
Mark AL, Abboud FM, Schmid PG, Heistad DD, Mayer UJ (1972) Differences in direct effects of adrenergic stimuli on coronary, cutaneous and muscular vessels. J Clin Invest 51: 279–287
Martin SE, Patterson RE (1989) Coronary constriction due to neuropeptide Y: Alleviation with cyclooxygenase blockers. Am J Physiol 257: H927–H934
Maruoka Y, McKirnan MD, Engler RL, Longhurst JC (1987) Punctional significance of alpha-adrenergic receptors in mature coronary collateral circulation of dogs. Am J Physiol 253: H582–H590
Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross Jr J (1984) Effects of β-blockade on regional myocardial flow and function during exercise. Am J Physiol 247: H52–H60
McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, Mac-Intyre I, Maseri A (1986) Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation 74: 1243–1247
McGrath JC (1982) Evidence for more than one type of postijunctional alphaadrenoceptor. Biochem Pharmacol 31: 467–484
McRaven DR, Mark AL, Abbond FM, Mayer HE (1971) Responses of coronary vessels to adrenergic stimuli. J Clin Invest 50: 773–778
Miller WL, Belardinelli L, Bacchus A, Foley DH, Rubio R, Berne RM (1979) Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation. Circ Res 45: 708–718
Miyamoto MI, Rockman HA, Guth BD, Heusch G, Ross Jr. J (1991) Effect of α-adrenergic stimulation on regional contractile function and myocardial blood flow with and without ischemia. Circulation 84: 1715–1724
Miyashiro JK, Feigl EO (1993) Feedforward control of coronary blood flow via coronary β-receptor stimulation. Circ Res 73: 252–263
Mohrman DE, Feigl EO (1978) Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 42: 79–86
Mudge GH, Goldberg S, Gunther S, Mann T, Grossman W (1979) Comparison of metabolic and vasoconstrictor stimuli on coronary vascular resistance in man. Circulation 59: 544–550
Mudge GH, Grossman W, Mills Jr RM, Lesch M, Braunwald E (1976) Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med 295: 1333–1337
Mueller HS, Rao PS, Rao PB, Gory DJ, Mudd JG, Ayres SM (1982) Enhanced transcardiac 1-norepinephrine response during cold pressor test in obstructive coronary artery disease. Am J Cardiol 50: 1223–1228
Murphree SS, Saffitz JE (1988) Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium. Circ Res 63: 117–125
Murray PA, Lavallee M, Vatner SF (1984) Alpha-adrenergic-mediated reduction in coronary blood flow secondary to carotid chemoreceptor reflex activation in conscious dogs. Circ Res 54: 96–106
Murray PA, Vatner SF (1979) α-adrenoceptor attenuation of coronary vascular response to severe exercise in the conscious dog. Circ Res 45: 654–660
Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77: 43–52
Nagata M, Pichet R, Lavallee M (1988) Coronary dilation with carotid chemoreceptor stimulation in cardiac-denervated dogs. Am J Physiol 255: H1330–H1335
Nakane T, Chiba S (1987) Postjunctional α-adrenoceptor subtypes in isolated and perfused canine epicardial coronary arteries. J Cardiovasc Pharmacol 10: 651–657
Nakane T, Tsujimoto G, Hashimoto K, Chiba S (1988) Beta adrenoceptors in the canine large coronary arteries: beta-1 adrenoceptors predominate in vasodilation. J Pharmacol Exp Ther 245: 936–943
Nathan HJ, Fiegl EO (1986) Adrenergic vasoconstriction lessens transmural steal during coronary hypoperfusion. Am J Physiol 250: H645–H653
Orlick AE, Ricci DR, Alderman EL, Stinson EB, Harrison DC (1978) Effects of alpha adrenergic blockade upon coronary hemodynamics. J Clin Invest 62: 459–467
Otani N, Yang T, Levy MN (1993) Intense sympathetic stimulation releases neuropeptide y but fails to evoke sustained coronary vasoconstriction in dogs. Circ Res 72: 816–826
RAff WK, Kosche F, Goebel H, Lochner W (1972) Coronary extravascular resistance at increasing left ventricular pressure. Pfluegers Arch 333: 352–361
Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ (1980) Provocation of coronary artery spasm by the cold pressor test. Circulation 62: 925–932
Reid JVO, Ito BR, Huang AH, Buffington CW, Feigl EO (1985) Parasympathetic control of transmural coronary blood flow in dogs. Am J Physiol 249: H337–H343
Rimele TJ, Rooke TW, Aarhus LL, Vanhoutte PM (1983) Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries. J Pharmacol Exp Ther 226: 668–672
Rinkema LE, Thomas Jr. JX, Randall WC (1982) Regional coronary vasoconstriction in response to stimulation of stellate ganglia. Am J Physiol 243: H410–H415
Robertson RM, Bernard YD, Carr RK, Robertson D (1983) Alphaadrenergic blockade in vasotonic angina: lack of efficacy of specific alphal-receptor blockade with prazosin. J Am Coll Cardiol 2: 1146–1150
Rosendorff C, Hoffman JIE, Verrier ED, Rouleau J, Boerboom LE (1981) Cholesterol potentiates the coronary artery response to norepinephrine in anesthetized and conscious dogs. Circ Res 48: 320–329
Rudehill A, Sollevi A, Franco-Cereceda A, Lundberg JM (1986) Neuropeptide Y (NPY) and the pig heart: Release and coronary vasoconstrictor effects. Peptides 7: 821–826
Saeed M, Holtz J, Elsner D, Bassenge E (1985) Sympathetic control of myocardial oxygen balance in dogs mediated by activation of coronary vascular α2-adrenoceptors. J Cardiovasc Pharmacol 7: 167–173
Schipke J, Heusch G, Deussen A, Thaemer V (1985) Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium. Drug Res 35: 926–929
Schulz R, Oudiz RJ, Guth BD, Heusch G (1990) Minimal α1- and α2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine. Naunyn Schmiedebergs Arch Pharmacol 342:422–428
Schwartz PJ, Stone HL (1977) Tonic influence of the sympathetic nervous system on myocardial reactive hyperemia and on coronary blood flow distribution in dogs. Circ Res 41: 51–58
Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, Ross Jr J (1988) Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62: 436–442
Seitelberger R, Guth BD, Lee JD, Katayama K, Heusch G, Ross Jr J (1986) Alpha1 and alpha2 receptor stimulation in conscious dogs increase coronary resistance but not myocardial function. J Am Coll Cardiol 7 (suppl A): 81A (abstr.)
Sekiguchi N, Kanatsuka H, Sato K, Wang Y, Akai K, Komaru T, Takishima T (1994) Effects of calcitonin generelated peptide on coronary microvessels and its role in acute myocardial ischemia. Circulation 89: 366–374
Sink JD, Hill RC, Chitwood Jr. WR, Abriss R, Wechsler AS (1979) Effects of phenylephrine on transmural distribution of myocardial blood flow in regions supplied by normal and collateral arteries during cardiopulmonary bypass. J Thorac Cardiovasc Surg 78: 236–243
Strader JR, Gwirtz PA, Jones CE (1988) Comparative effects of α1- and α2-adrenoceptors in modulation of coronary flow during exercise. J Pharmacol Exp Ther 246: 772–778
Toda N (1986) Alpha-adrenoceptor subtypes and diltiazem actions in isolated human coronary arteries. Am J Physiol 250: H718–H724
Tzivoni D, Keren A, Benhorin J, Gottlieb S, Atlas D, Stern S (1983) Prazosin therapy for refractory variant angina. Am Heart J 105: 262–266
Ullman B, Hulting J, Lundberg JM (1994) Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J 15: 454–461
Uren NG, Seydoux C, Davies GJ (1993) Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc Res 27: 1477–1481
Van Winkle DM, Feigl EO (1989) Acetylcholine causes coronary vasodilation in dogs and baboons. Circ Res 65: 1580–1593
Vatner DE, Knight DR, Homcy CJ, Vatner SF, Young MA (1986) Subtypes of β-adrenergic receptors in bovine coronary arteries. Circ Res 59: 463–473
Vatner SF, Hintze TH (1983) Mechanism of constriction of large coronary arteries by β-adrenergic receptor blockade. Circ Res 53: 389–400
Vatner SF, Hintze TH, Macho P (1982) Regulation of large coronary arteries by β-adrenergic mechanisms in the conscious dog. Circ Res 51: 56–66
Vatner SF, McRitchie RJ (1975) Interaction of the chemoreflex and the pulmonary inflation reflex in the regulation of coronary circulation in conscious dogs. Circ Res 37: 664–673
Vlahakes GJ, Baer RW, Uhlig PN, Verrier ED, Bristow JD, Hoffman JIE (1982) Adrenergic influence in the coronary circulation of conscious dogs during maximal vasodilation with adenosine. Circ Res 51: 371–384
von Restorff W, Bassenge E (1977) Transient effects of norepinephrine on myocardial oxygen balance. Pfluegers Arch 370: 131–137
Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B (1989) Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 79: 287–291
Wilson FR, Marcus ML, White CW (1988) Pulmonary inflation reflex: its lack of physiological significance in coronary circulation of humans. Am J Physiol 255: H866–H871
Winniford MD, Filipchuk N, Hillis LD (1983) Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial. Circulation 67: 1185–1188
Woodman OL (1987) The role of α1- and α2-adrenoceptors in the coronary vasoconstrictor responses to neurally released and exogenous noradrenaline in the dog. Naunyn Schmiedebergs Arch Pharmacol 336: 161–168
Woodman OL, Vatner SF (1987) Coronary vasoconstriction mediated by α1- and α2-adrenoceptors in conscious dogs. Am J Physiol 253: H388–H393
Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F (1976) Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91: 148–155
Young MA, Knight DR, Vatner SF (1987) Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 30: 211–234
Young MA, Knight DR, Vatner SF (1988) Parasympathetic coronary vasoconstriction induced by nicotine in conscious calves. Circ Res 62: 891–895
Young MA, Vatner DE, Knight DR, Graham RM, Homcy CJ, Vatner SF (1988) α-adrenergic vasoconstriction and receptor subtypes in large coronary arteries of calves. Am J Physiol 255: H1452–H1459
Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H (1989) Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14: 1181–1190
Zeiher AM, Drexler H, Wollschläger H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391–401
Zucker IH, Cornish KG, Hackley J, Bliss K (1987) Effects of left ventricular receptor stimulation on coronary blood flow in conscious dogs. Circ Res 61 (suppl II): II54-II60
Author information
Authors and Affiliations
Additional information
Invited Contributions to the Symposium “Regulation of coronary blood flow”, held at the XV. World Congress of the International Society for Heart Research in Prague 1995
Professor William M. Chilian, College Station, USA, was responsible for the editorial decisions on this manuscript. This policy applies to all manuscripts with authors from the editor's institution.
Rights and permissions
About this article
Cite this article
Baumgart, D., Heusch, G. Neuronal control of coronary blood flow. Basic Res Cardiol 90, 142–159 (1995). https://doi.org/10.1007/BF00789444
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00789444